-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 24, the official website of the State Food and Drug Administration showed that Chengdu Bite Pharmaceutical's oseltamivir phosphate capsules and oseltamivir phosphate dry suspension were approved on the same day
.
According to data from Minet.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
.
According to data from Minet.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
March 24, 2022 Information release of drug approval certificate pending collection
According to data from Minet.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
Currently, oseltamivir formulations are available in granules, capsules and dry suspensions
.
For capsules, there are 8 companies with production approvals, including Roche, Yichang Dongguang Changjiang Pharmaceutical, CSPC Ouyi Pharmaceutical, Sichuan Kelun Pharmaceutical, and Chengdu Beite Pharmaceutical.
There is only one granule in Yichang Dongguang Changjiang Pharmaceutical.
With production approvals, 2 dry suspensions have production approvals, and Chengdu Bite Pharmaceutical won the first imitation
.
.
For capsules, there are 8 companies with production approvals, including Roche, Yichang Dongguang Changjiang Pharmaceutical, CSPC Ouyi Pharmaceutical, Sichuan Kelun Pharmaceutical, and Chengdu Beite Pharmaceutical.
There is only one granule in Yichang Dongguang Changjiang Pharmaceutical.
With production approvals, 2 dry suspensions have production approvals, and Chengdu Bite Pharmaceutical won the first imitation
.
Production of Oseltamivir Phosphate Dry Suspension under Review
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
In addition, more than 10 companies including Anhui Pioneer Pharmaceutical, Yangzijiang Pharmaceutical Group, and Chongqing Shenghuaxi Pharmaceutical have submitted their listing applications for Oseltamivir Phosphate Capsules under review and approval
.
For oseltamivir phosphate dry suspension, more than 10 companies including Shijiazhuang No.
4 Medicines, Lepu Pharmaceuticals, Qilu Pharmaceuticals (Hainan), etc.
have submitted listing applications for review and approval, and the competition is fierce
.
.
For oseltamivir phosphate dry suspension, more than 10 companies including Shijiazhuang No.
4 Medicines, Lepu Pharmaceuticals, Qilu Pharmaceuticals (Hainan), etc.
have submitted listing applications for review and approval, and the competition is fierce
.
Neither Oseltamivir Phosphate Orally Disintegrating Tablets nor Oseltamivir Phosphate Dry Syrup has been approved.
Among them, Oseltamivir Phosphate Oral Disintegrating Tablets are only under review and approval by Beijing Xinghao Pharmaceutical .
For Oseltamivir Phosphate Dry Syrup, 4 companies including Jiangxi Shimei Pharmaceutical Co.
, Ltd.
and Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co.
, Ltd.
have submitted their listing applications for review and approval
.
Among them, Oseltamivir Phosphate Oral Disintegrating Tablets are only under review and approval by Beijing Xinghao Pharmaceutical .
For Oseltamivir Phosphate Dry Syrup, 4 companies including Jiangxi Shimei Pharmaceutical Co.
, Ltd.
and Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co.
, Ltd.
have submitted their listing applications for review and approval
.
Source: State Food and Drug Administration official website, Minet database
Note: Minet.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 urban physical pharmacies in cities and above (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 urban physical pharmacies in cities and above (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
On March 24, the official website of the State Food and Drug Administration showed that Chengdu Bite Pharmaceutical's oseltamivir phosphate capsules and oseltamivir phosphate dry suspension were approved on the same day
.
According to data from Minet.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
.
According to data from Minet.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
March 24, 2022 Information release of drug approval certificate pending collection
According to data from Minet.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
Currently, oseltamivir formulations are available in granules, capsules and dry suspensions
.
For capsules, there are 8 companies with production approvals, including Roche, Yichang Dongguang Changjiang Pharmaceutical, CSPC Ouyi Pharmaceutical, Sichuan Kelun Pharmaceutical, and Chengdu Beite Pharmaceutical.
There is only one granule in Yichang Dongguang Changjiang Pharmaceutical.
With production approvals, 2 dry suspensions have production approvals, and Chengdu Bite Pharmaceutical won the first imitation
.
.
For capsules, there are 8 companies with production approvals, including Roche, Yichang Dongguang Changjiang Pharmaceutical, CSPC Ouyi Pharmaceutical, Sichuan Kelun Pharmaceutical, and Chengdu Beite Pharmaceutical.
There is only one granule in Yichang Dongguang Changjiang Pharmaceutical.
With production approvals, 2 dry suspensions have production approvals, and Chengdu Bite Pharmaceutical won the first imitation
.
Production of Oseltamivir Phosphate Dry Suspension under Review
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
In addition, more than 10 companies including Anhui Pioneer Pharmaceutical, Yangzijiang Pharmaceutical Group, and Chongqing Shenghuaxi Pharmaceutical have submitted their listing applications for Oseltamivir Phosphate Capsules under review and approval
.
For oseltamivir phosphate dry suspension, more than 10 companies including Shijiazhuang No.
4 Medicines, Lepu Pharmaceuticals, Qilu Pharmaceuticals (Hainan), etc.
have submitted listing applications for review and approval, and the competition is fierce
.
.
For oseltamivir phosphate dry suspension, more than 10 companies including Shijiazhuang No.
4 Medicines, Lepu Pharmaceuticals, Qilu Pharmaceuticals (Hainan), etc.
have submitted listing applications for review and approval, and the competition is fierce
.
Neither Oseltamivir Phosphate Orally Disintegrating Tablets nor Oseltamivir Phosphate Dry Syrup has been approved.
Among them, Oseltamivir Phosphate Oral Disintegrating Tablets are only under review and approval by Beijing Xinghao Pharmaceutical .
For Oseltamivir Phosphate Dry Syrup, 4 companies including Jiangxi Shimei Pharmaceutical Co.
, Ltd.
and Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co.
, Ltd.
have submitted their listing applications for review and approval
.
Among them, Oseltamivir Phosphate Oral Disintegrating Tablets are only under review and approval by Beijing Xinghao Pharmaceutical .
For Oseltamivir Phosphate Dry Syrup, 4 companies including Jiangxi Shimei Pharmaceutical Co.
, Ltd.
and Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co.
, Ltd.
have submitted their listing applications for review and approval
.
Source: State Food and Drug Administration official website, Minet database
Note: Minet.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 urban physical pharmacies in cities and above (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 urban physical pharmacies in cities and above (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
On March 24, the official website of the State Food and Drug Administration showed that Chengdu Bite Pharmaceutical's oseltamivir phosphate capsules and oseltamivir phosphate dry suspension were approved on the same day
.
According to data from Minet.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
.
According to data from Minet.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
March 24, 2022 Information release of drug approval certificate pending collection
According to data from Minet.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
com, in 2020, the total sales of oseltamivir in terminals of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 3 billion yuan
.
Currently, oseltamivir formulations are available in granules, capsules and dry suspensions
.
For capsules, there are 8 companies with production approvals, including Roche, Yichang Dongguang Changjiang Pharmaceutical, CSPC Ouyi Pharmaceutical, Sichuan Kelun Pharmaceutical, and Chengdu Beite Pharmaceutical.
There is only one granule in Yichang Dongguang Changjiang Pharmaceutical.
With production approvals, 2 dry suspensions have production approvals, and Chengdu Bite Pharmaceutical won the first imitation
.
.
For capsules, there are 8 companies with production approvals, including Roche, Yichang Dongguang Changjiang Pharmaceutical, CSPC Ouyi Pharmaceutical, Sichuan Kelun Pharmaceutical, and Chengdu Beite Pharmaceutical.
There is only one granule in Yichang Dongguang Changjiang Pharmaceutical.
With production approvals, 2 dry suspensions have production approvals, and Chengdu Bite Pharmaceutical won the first imitation
.
Production of Oseltamivir Phosphate Dry Suspension under Review
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
In addition, more than 10 companies including Anhui Pioneer Pharmaceutical, Yangzijiang Pharmaceutical Group, and Chongqing Shenghuaxi Pharmaceutical have submitted their listing applications for Oseltamivir Phosphate Capsules under review and approval
.
For oseltamivir phosphate dry suspension, more than 10 companies including Shijiazhuang No.
4 Medicines, Lepu Pharmaceuticals, Qilu Pharmaceuticals (Hainan), etc.
have submitted listing applications for review and approval, and the competition is fierce
.
enterprise enterprise enterprise.
For oseltamivir phosphate dry suspension, more than 10 companies including Shijiazhuang No.
4 Medicines, Lepu Pharmaceuticals, Qilu Pharmaceuticals (Hainan), etc.
have submitted listing applications for review and approval, and the competition is fierce
.
Neither Oseltamivir Phosphate Orally Disintegrating Tablets nor Oseltamivir Phosphate Dry Syrup has been approved.
Among them, Oseltamivir Phosphate Oral Disintegrating Tablets are only under review and approval by Beijing Xinghao Pharmaceutical .
For Oseltamivir Phosphate Dry Syrup, 4 companies including Jiangxi Shimei Pharmaceutical Co.
, Ltd.
and Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co.
, Ltd.
have submitted their listing applications for review and approval
.
medicine medicine medicineAmong them, Oseltamivir Phosphate Oral Disintegrating Tablets are only under review and approval by Beijing Xinghao Pharmaceutical .
For Oseltamivir Phosphate Dry Syrup, 4 companies including Jiangxi Shimei Pharmaceutical Co.
, Ltd.
and Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co.
, Ltd.
have submitted their listing applications for review and approval
.
Source: State Food and Drug Administration official website, Minet database
Note: Minet.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 urban physical pharmacies in cities and above (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
pharmacy pharmacy pharmacy com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 urban physical pharmacies in cities and above (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
